These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 6729733)

  • 21. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 22. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intravenous proscillaridin A in cardiotonic therapy of the senile heart].
    Massoni G
    G Gerontol; 1968 Sep; 16(9):975-8. PubMed ID: 5754030
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of patients with ischemic heart disease in the initial stage of heart failure using strophanthin electrophoresis].
    Rozdil'skaia ON; Rozdil'skiĭ OI; Tondiĭ LD; Shtern MR
    Vrach Delo; 1990 Mar; (3):52-5. PubMed ID: 2368361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of anabolic preparations in atherosclerotic cardiosclerosis].
    Agapova EN; Tkachenko AM; Krutovskaia OV
    Klin Med (Mosk); 1974 Jan; 52(1):42-4. PubMed ID: 4466884
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of heart failure in hypertension].
    Linss G; Scholze J
    Z Arztl Fortbild (Jena); 1985; 79(17):727-32. PubMed ID: 2932861
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the indices of external respiration and central hemodynamics during the use of nitrates in the therapy of chronic heart failure].
    Samiev UB
    Ter Arkh; 1984; 56(9):58-62. PubMed ID: 6515550
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in the therapy with cardiac glycosides].
    Rietbrock N
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):539-40. PubMed ID: 6808381
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problems in the use of cardiac glycosides in ischemic heart disease].
    Modersohn D; Urbaszek W
    Z Gesamte Inn Med; 1975 Aug; 30(15):502-6. PubMed ID: 1189495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [On the problem of the method of prolonged use of cardiac glycosides in patients with mitral defects and chronic circulatory insufficiency].
    Kats GL
    Sov Med; 1967 Apr; 30(4):79-83. PubMed ID: 5608582
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of vitamin B 15 on myocardial contractility and cardiotonic effect of strophanthin in ischaemic heart disease.
    Apanasenko AA
    Cor Vasa; 1973; 15(1):20-8. PubMed ID: 4703670
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of milurite in ischemic heart disease].
    Teslenko VG; Khimenko LP
    Vrach Delo; 1980 Oct; (10):18-21. PubMed ID: 7434694
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
    Grujić M; Perinović M; Ljubojević S
    Med Arh; 1977; 31(3):171-5. PubMed ID: 333198
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronesthesia to cardiac glycosides of patients with cardiac failure.
    Zaslavskaya RM; Vilkovysky PA; Goncharov LP; Varshitsky BG
    Prog Clin Biol Res; 1990; 341A():377-82. PubMed ID: 2217255
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
    Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
    Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The possibility of targeted pharmacological action on the intravascular binding of calcium ions: a new aspect of pharmacodynamics?].
    Kolomiets VV; Merzon KA
    Ter Arkh; 1987; 59(9):86-90. PubMed ID: 3424197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of the coronary syndrome and cardiac failure. Experiences with Adenylocrat and Adenylocrat-Digoxin].
    Vargha A
    Munch Med Wochenschr; 1970 Dec; 112(49):2247-51. PubMed ID: 5536817
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 40. [A disorder of myocardial contractile function in acute experimental coronary failure: the submolecular mechanisms and the action of cardiac glycosides].
    Karsanov NV; Sukoian GV; Tatulashvili DR; Karsanov VN; Guledani NE
    Eksp Klin Farmakol; 2000; 63(2):24-34. PubMed ID: 10834090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.